These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26407252)

  • 1. (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.
    Salvatore CM; Chen TK; Toussi SS; DeLaMora P; Petraitiene R; Finkelman MA; Walsh TJ
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):277-86. PubMed ID: 26407252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid.
    Forster J; Hoenigl M; Suerbaum S; Wagener J; Dichtl K
    Mycoses; 2022 Jul; 65(7):709-714. PubMed ID: 35506957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection.
    Lyons JL; Thakur KT; Lee R; Watkins T; Pardo CA; Carson KA; Markley B; Finkelman MA; Marr KA; Roos KL; Zhang SX
    J Clin Microbiol; 2015 Jan; 53(1):319-22. PubMed ID: 25378578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging diagnosis of chronic cerebral fungal infection: Value of (1→3)-ß-D-glucan and mannan antigen testing in cerebrospinal fluid and of cerebral ventricle puncture.
    Hobson CA; Desoubeaux G; Carvalho-Schneider C; Destrieux C; Cottier JP; Garot D; Le Brun C; Maakaroun Z; Lemaignen A; Bailly É; Bernard L
    Med Mycol; 2021 Jan; 59(1):74-80. PubMed ID: 32470986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis.
    Myint T; Chow FC; Bloch KC; Raymond-Guillen L; Davis TE; Wright PW; Woc-Colburn L; Khairy RN; Street AC; Yamamoto T; Albers A; Wheat LJ; Hage CA
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30021828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species.
    Mokaddas E; Burhamah MH; Khan ZU; Ahmad S
    BMC Infect Dis; 2010 Oct; 10():292. PubMed ID: 20923575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.
    Litvintseva AP; Lindsley MD; Gade L; Smith R; Chiller T; Lyons JL; Thakur KT; Zhang SX; Grgurich DE; Kerkering TM; Brandt ME; Park BJ
    Clin Infect Dis; 2014 Mar; 58(5):622-30. PubMed ID: 24336827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.
    Mularoni A; Furfaro E; Faraci M; Franceschi A; Mezzano P; Bandettini R; Viscoli C; Castagnola E
    Clin Vaccine Immunol; 2010 May; 17(5):882-3. PubMed ID: 20335432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal meningitis associated with contaminated methylprednisolone injections.
    Malani AN; Singal B; Wheat LJ; Al Sous O; Summons TA; Durkin MM; Pettit AC
    J Clin Microbiol; 2015 Mar; 53(3):799-803. PubMed ID: 25540391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
    Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
    Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
    Alam FF; Mustafa AS; Khan ZU
    BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
    Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
    BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system candidiasis beyond neonates: Lessons from a nationwide study.
    Chaussade H; Cazals X; Desoubeaux G; Jouvion G; Bougnoux ME; Lefort A; Rivoisy C; Desnos-Ollivier M; Chretien F; Chouaki T; Gruson B; Bernard L; Lortholary O; Lanternier F;
    Med Mycol; 2021 Mar; 59(3):266-277. PubMed ID: 32577733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
    Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
    Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis.
    Rhein J; Bahr NC; Morawski BM; Schutz C; Zhang Y; Finkelman M; Meya DB; Meintjes G; Boulware DR
    Open Forum Infect Dis; 2014 Dec; 1(3):ofu105. PubMed ID: 25734173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
    Metan G; Ağkuş C; Buldu H; Koç AN
    Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay.
    Hummel M; Spiess B; Kentouche K; Niggemann S; Böhm C; Reuter S; Kiehl M; Mörz H; Hehlmann R; Buchheidt D
    J Clin Microbiol; 2006 Nov; 44(11):3989-93. PubMed ID: 16943359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.